The prognostic significance of human papilloma virus in sinonasal squamous cell carcinoma. Issue 6 (4th November 2020)

• Record Type: Journal Article
• Authors: Schlussel Markovic, Emily; Marqueen, Kathryn E.; Sindhu, Kunal K.; Lehrer, Eric J.; Liu, Jerry; Miles, Brett; Genden, Eric; Sharma, Sonam; Gupta, Vishal; Westra, William; Iloreta, Alfred; Posner, Marshall; Misiukiewicz, Krzysztof; Bakst, Richard L.
• Is Part Of: Laryngoscope investigative otolaryngology. Volume 5:Issue 6(2020)
• Page Start: 1070
• Page End: 1078
• Publication Date: 2020-11-04
• Subjects: human papilloma virus (HPV) -- prognosis -- sinonasal carcinoma; Otolaryngology -- Periodicals; Laryngoscopy -- Periodicals; Otolaryngology; Otolaryngology; Periodicals; Periodicals; 617.51
• DOI: 10.1002/lio2.468
• Languages: English
• ISSNs: 2378-8038

Abstract

Abstract: Background: Human papilloma virus (HPV) has been implicated in the pathology of oropharyngeal head and neck cancers, but its role in sinonasal squamous cell carcinoma (SNSCC) has not been well established. Methods: Thirty‐two patients with SNSCC diagnosed between 2011 and 2018 were identified and stratified by HPV status and viral serotype, as determined by PCR. Endpoints including recurrence, metastases and survival were analyzed using the Kaplan‐Meier method. Results: Seventeen (53%) patients were HPV‐positive and 15 (47%) were HPV‐negative. The median follow‐up time of living patients was 30.7 months (range 4‐123 months). Survival did not differ by HPV status, but HPV+ tumors were more likely to locally recur and metastasize. When stratifying by treatment type, the lowest rate of recurrence occurred in patients receiving surgery and chemoradiation. Conclusion: A significant proportion of sinonasal tumors appear to be associated with HPV. Testing for HPV might be justified in all cases of sinonasal cancers. Further investigation is warranted to better understand the role of HPV in SNSCC.